Araştırma Makalesi

Evaluation of serum omentin, osteoprotegerin and malondialdehyde levels in women with polycystic ovary syndrome: a prospective case-control study

Cilt: 41 Sayı: 1 23 Mart 2016
Mustafa Dereli , Ulaş Solmaz , Atalay Ekin , Emre Mat , Cenk Gezer , Gökhan Tosun , Ümit Çabuş , Gökben Yüksel , İbrahim Fenkçi
PDF İndir
EN TR

Evaluation of serum omentin, osteoprotegerin and malondialdehyde levels in women with polycystic ovary syndrome: a prospective case-control study

Öz

Purpose: The aim of this study was to evaluate the serum levels of omentin, osteoprotegerin and malondialdehyde levels in patients with polycystic ovary syndrome (PCOS).

Material and Methods: This prospective case-control study included 31 patients with the diagnosis of PCOS and 33 healthy cases as a control group. Both groups were compared according to demographic characteristics, antropometric measurements, levels of biochemical parameters and serum levels of omentin, osteoprotegerin and malondialdehyde.

Results: When compared with control group, patients in PCOS group were found to have statistically significantly lower age but have higher hirsutism score, fasting glucose level, total testosteron level, free androgen index, LH level and LH/FSH ratio. There was no statistically significant difference among PCOS and control groups in terms of serum omentin, osteoprotegerin and malondialdehyde levels.

Conclusion: No significant change was shown in the levels of serum omentin, osteoprotegerin and malondealdeheyde levels in women with PCOS. 

Anahtar Kelimeler

-

Kaynakça

  1. Kaynakça Bulunmuyor

Kaynak Göster

APA
Dereli, M., Solmaz, U., Ekin, A., Mat, E., Gezer, C., Tosun, G., Çabuş, Ü., Yüksel, G., & Fenkçi, İ. (2016). Evaluation of serum omentin, osteoprotegerin and malondialdehyde levels in women with polycystic ovary syndrome: a prospective case-control study. Cukurova Medical Journal, 41(1), 1-7. https://doi.org/10.17826/cutf.147385
AMA
1.Dereli M, Solmaz U, Ekin A, vd. Evaluation of serum omentin, osteoprotegerin and malondialdehyde levels in women with polycystic ovary syndrome: a prospective case-control study. Cukurova Med J. 2016;41(1):1-7. doi:10.17826/cutf.147385
Chicago
Dereli, Mustafa, Ulaş Solmaz, Atalay Ekin, vd. 2016. “Evaluation of serum omentin, osteoprotegerin and malondialdehyde levels in women with polycystic ovary syndrome: a prospective case-control study”. Cukurova Medical Journal 41 (1): 1-7. https://doi.org/10.17826/cutf.147385.
EndNote
Dereli M, Solmaz U, Ekin A, Mat E, Gezer C, Tosun G, Çabuş Ü, Yüksel G, Fenkçi İ (01 Mart 2016) Evaluation of serum omentin, osteoprotegerin and malondialdehyde levels in women with polycystic ovary syndrome: a prospective case-control study. Cukurova Medical Journal 41 1 1–7.
IEEE
[1]M. Dereli vd., “Evaluation of serum omentin, osteoprotegerin and malondialdehyde levels in women with polycystic ovary syndrome: a prospective case-control study”, Cukurova Med J, c. 41, sy 1, ss. 1–7, Mar. 2016, doi: 10.17826/cutf.147385.
ISNAD
Dereli, Mustafa - Solmaz, Ulaş - Ekin, Atalay - Mat, Emre - Gezer, Cenk - Tosun, Gökhan - Çabuş, Ümit - Yüksel, Gökben - Fenkçi, İbrahim. “Evaluation of serum omentin, osteoprotegerin and malondialdehyde levels in women with polycystic ovary syndrome: a prospective case-control study”. Cukurova Medical Journal 41/1 (01 Mart 2016): 1-7. https://doi.org/10.17826/cutf.147385.
JAMA
1.Dereli M, Solmaz U, Ekin A, Mat E, Gezer C, Tosun G, Çabuş Ü, Yüksel G, Fenkçi İ. Evaluation of serum omentin, osteoprotegerin and malondialdehyde levels in women with polycystic ovary syndrome: a prospective case-control study. Cukurova Med J. 2016;41:1–7.
MLA
Dereli, Mustafa, vd. “Evaluation of serum omentin, osteoprotegerin and malondialdehyde levels in women with polycystic ovary syndrome: a prospective case-control study”. Cukurova Medical Journal, c. 41, sy 1, Mart 2016, ss. 1-7, doi:10.17826/cutf.147385.
Vancouver
1.Mustafa Dereli, Ulaş Solmaz, Atalay Ekin, Emre Mat, Cenk Gezer, Gökhan Tosun, Ümit Çabuş, Gökben Yüksel, İbrahim Fenkçi. Evaluation of serum omentin, osteoprotegerin and malondialdehyde levels in women with polycystic ovary syndrome: a prospective case-control study. Cukurova Med J. 01 Mart 2016;41(1):1-7. doi:10.17826/cutf.147385